Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Plos One|April 29, 2021
Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeksDavid T Arnold, Charmaine Donald, Max Lyon, et al.
BMC Cancer|February 19, 2018
A prospective study to investigate the role of serial serum mesothelin in monitoring mesotheliomaDuneesha de Fonseka, David T Arnold, Louise Stadon, et al.
Chest|December 28, 2016
Nonmalignant Pleural Effusions: A Prospective Study of 356 Consecutive Unselected PatientsSteven P Walker, Anna J Morley, Louise Stadon, et al.
BMC Pulmonary Medicine|August 30, 2022
A feasibility randomised trial comparing therapeutic thoracentesis to chest tube insertion for the management of pleural infection: results from the ACTion trialDavid T Arnold, Emma Tucker, Anna Morley, et al.
BMC Pulmonary Medicine|May 3, 2022
Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesotheliomaDuneesha De Fonseka, David T Arnold, Anna J Morley, et al.
American Journal of Respiratory and Critical Care Medicine|February 19, 2020
Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic EffusionsDavid T Arnold, Fergus W Hamilton, Karen T Elvers, et al.
Plos One|February 4, 2015
Pleural fluid adenosine deaminase (pfADA) in the diagnosis of tuberculous effusions in a low incidence populationDavid T Arnold, Rahul Bhatnagar, Lynette D Fairbanks, et al.
Thorax|July 4, 2024
Antibiotic pharmacokinetics in infected pleural effusionsDavid T Arnold, Liam Read, Oliver Waddington, et al.
Emergency Medicine Journal : EMJ|May 22, 2021
Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort studyDavid T Arnold, Marie Attwood, Shaney Barratt, et al.
The European Respiratory Journal|December 18, 2020
Epidemiology of pleural empyema in English hospitals and the impact of influenzaDavid T Arnold, Fergus W Hamilton, Tim T Morris, et al.
Pageof 3